People In The News | GenomeWeb

NEW YORK (GenomeWeb News) – Enzo Biochem's shareholders have re-elected Barry Weiner and Bernard Kasten to continue serving on its board of directors for three-year terms, the company said in a filing with the US Securities and Exchange Commission this week.

Weiner is the company’s president, CFO, and principal accounting officer.


Lumora said this week that it has appointed Hayden Jeffreys to its board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.